-

Amwell to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:

  • Cowen’s 42nd Annual Health Care Conference including a fireside chat presentation on Tuesday, March 8, 2022 at 9:10 a.m. ET. Ido Schoenberg, Co-Chief Executive Officer and Robert Shepardson, Chief Financial Officer, will be participating.
  • Keybanc’s Virtual Healthcare Conference including a fireside chat presentation on Tuesday, March 22, 2022 at 2:15 p.m. ET. Roy Schoenberg, Co-Chief Executive Officer and Robert Shepardson, Chief Financial Officer, will be participating.

Audio webcasts will be available online at https://investors.amwell.com.

About Amwell

Amwell is a leading enterprise software company enabling digital delivery of care for healthcare’s key stakeholders in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The Company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers the digital care programs of over 55 health plans, which collectively represent more than 80 million covered lives, as well as approximately 150 of the nation’s largest health systems, encompassing more than 2,000 hospitals. For more information, please visit https://business.amwell.com.

American Well, Amwell, Converge, Conversa, SilverCloud and Carepoint are registered trademarks or trademarks of American Well Corporation in the United States and other countries. All other trademarks used herein are the property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in our most recent form 10-K filed with the SEC. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of our website at investors.amwell.com and on the SEC’s website at www.sec.gov.

Contacts

Media:
Lindsay Sharifipour
press@amwell.com
508-494-3422

Investor:
Asher Dewhurst
investors@amwell.com

Amwell

NYSE:AMWL

Release Versions

Contacts

Media:
Lindsay Sharifipour
press@amwell.com
508-494-3422

Investor:
Asher Dewhurst
investors@amwell.com

More News From Amwell

Amwell® Announces Results for Fourth Quarter 2021 and Full Year 2021

BOSTON--(BUSINESS WIRE)--Amwell® (NYSE: AMWL) (the "Company"), a leading enterprise software company enabling digital delivery of care for healthcare’s key stakeholders, today announced financial results for the fourth quarter and full year ended December 31, 2021. “Our fourth quarter marks a strong end to a strategic year. We continue to make meaningful progress on the launch and implementation of Converge™, our scalable, omnichannel platform designed to enable trusted healthcare players to de...

Amwell to Report Fourth Quarter and Full Year 2021 Operating Results and Host Conference Call on Thursday, February 24, 2022

BOSTON--(BUSINESS WIRE)--Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced that it will report fourth quarter and full year ended December 31, 2021 operating results on Thursday, February 24, 2022. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update. A live audio webcast c...

Amwell® Announces Results for Third Quarter 2021

BOSTON--(BUSINESS WIRE)--Amwell® (NYSE: AMWL) (the "Company"), a national telehealth leader, today announced financial results for the third quarter ended September 30, 2021. “In the third quarter, we were pleased to see further acceleration of user adoption and use case expansion on the Amwell platform. This was demonstrated by strong growth in active providers and recurring consumer visits. The transition to Converge is moving forward well. The addition of Conversa® Health and SilverCloud® He...
Back to Newsroom